Treatment of Bone Marrow Failure Syndrome with Integrated Traditional and Western Medicine
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Hu H, Chen T, Liu W, Shen Y, Li Q, Zhou Y J Blood Med. 2021; 12:975-989.
PMID: 34803418 PMC: 8598128. DOI: 10.2147/JBM.S332171.
Realgar (α-AsS) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation.
Zhang M, Zhang J, Sun M, Lu P, Liu J Chin J Integr Med. 2020; 28(3):281-288.
PMID: 32418175 DOI: 10.1007/s11655-020-3263-8.
Zhang M, Guo L, Lin L, Qu C, Yin X, Luo S Evid Based Complement Alternat Med. 2018; 2018:6493630.
PMID: 30258467 PMC: 6146668. DOI: 10.1155/2018/6493630.
References
1.
Frickhofen N, Heimpel H, Kaltwasser J, Schrezenmeier H
. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2002; 101(4):1236-42.
DOI: 10.1182/blood-2002-04-1134.
View
2.
PIZZUTO J, Conte G, Sinco A, Morales M, Aviles A, Ambriz R
. Use of androgens in acquired aplastic anaemia. Relation of response to aetiology and severity. Acta Haematol. 1980; 64(1):18-24.
DOI: 10.1159/000207205.
View
3.
Mentzel U, Vogt H, Rossol R, Geissler R, Maurer A, Ganser A
. Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy. Ann Hematol. 1993; 66(3):127-9.
DOI: 10.1007/BF01697621.
View
4.
NAJEAN Y
. Long-term follow-up in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Joint Group for the Study of Aplastic and Refractory Anemias. Am J Med. 1981; 71(4):543-51.
DOI: 10.1016/0002-9343(81)90204-7.
View
5.
Zhou A, Wang T, Yang J
. [Clinical study on treatment of aplastic anemia mainly with Yishen Shengxue tablet]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001; 18(10):603-6.
View